ADAR1 Capital Management »

Anavex Life Sciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $150k 16k 9.22
2025-03-31 $139k 16k 8.58
2024-12-31 $174k 16k 10.74

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Anavex Life Sciences

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Susquehanna International
Two Sigma Investments
Nwam
Northern Trust
Two Sigma Advisers
Charles Schwab Investment Management
Citadel Advisors
Morgan Stanley
LPL Financial
UBS Group
Private Advisor

View all funds holding Anavex Life Sciences